HMOX1 and breast carcinoma: Prostate cancer, NSCLC, hepatocellular carcinoma, breast cancer, pancreatic cancer, and CRC have been shown in studies to be inhibited by HO-1 expression [45,68,69,70,71,72,73,74,75].